← Eichor
Condition: Controlled Human Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Controlled Human Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT04231565Covid-19 and Influenza Oral Vaccine Study
Phase 1 · 1 location(s) · Vaxine Pty Ltd · NCT06355232A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-A1 in Healthy Young Adults
Phase 1 · 1 location(s) · Vaxcyte, Inc. · NCT07616934A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear S
Phase 3 · 1 location(s) · Huahui Health · NCT07499544A Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Partici
Phase 2 · 11 location(s) · SynAct Pharma Aps · NCT07633288Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis
Phase 1 · 1 location(s) · Dalhousie University · NCT06827470Immune Defense Protein Impact On Respiratory Immune Outcomes
NA · 1 location(s) · Quantec Ltd · NCT07431840First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07169318Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine
Phase 1/Phase 2 · 7 location(s) · Aramis Biotechnologies Inc. · NCT07291635Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract In
Phase 3 · 1 location(s) · Kexing Biopharm Co., Ltd. · NCT06363370Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loads
NA · 10 location(s) · Guangzhou 8th People's Hospital · NCT06947356Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute
Phase 1/Phase 2 · 3 location(s) · PEACHES BIOTECH · NCT06684379Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study)
Phase 1 · 1 location(s) · Aarhus University Hospital · NCT06668727Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
Phase 4 · 1 location(s) · Taichung Veterans General Hospital · NCT03933384A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
Phase 2 · 10 location(s) · Naga P. Chalasani · NCT07143968Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections.
Phase 4 · 12 location(s) · Labo'Life · NCT04232917Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15
Phase 4 · 2 location(s) · University of Oxford · NCT06731374Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
Phase 4 · 1 location(s) · Mercy Medical Center · NCT04588077A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults
Phase 1 · 1 location(s) · Chimivac INC · NCT07059403Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)
Phase 3 · 1 location(s) · Dre Pauline Vetter · NCT06653569SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
Phase 4 · 1 location(s) · Chinese University of Hong Kong · NCT06364930A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Wome
Phase 3 · 8 location(s) · National Vaccine and Serum Institute, China · NCT05262010Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT04422366Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytolo
Phase 2 · 1 location(s) · Amplexd Therapeutics, Inc. · NCT07572396Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）
NA · 1 location(s) · Qing XIe · NCT06323681Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme Trial
NA · 4 location(s) · Universiti Putra Malaysia · NCT06815250Effect of Different HPV Education Methods on Vaccination Intention in Young Women
NA · 1 location(s) · Emel GÜÇLÜ CİHAN · NCT07420556First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133
Phase 1 · 2 location(s) · University Hospital Tuebingen · NCT06290557Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults
Phase 1 · 1 location(s) · U.S. Army Medical Research and Development Command · NCT06205056First Time in Human Study of Long Acting VH4524184 Formulations
Phase 1 · 3 location(s) · ViiV Healthcare · NCT06310551
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.